Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Rheumatoid Arthritis

Free Subscription Articles published in Scand J Rheumatol Retrieve available abstracts of 81 articles: HTML format

Single Articles

May 2024
1. PROVAN SA, Ahlfors F, Bakland G, Hu Y, et al
   A validation of register-derived diagnoses of interstitial lung disease in patients with inflammatory arthritis: data from the NOR-DMARD study.
   Scand J Rheumatol. 2024;53:173-179.
   PubMed     Abstract available
   
   
   
2. GERTEL S, Rokach M, Polachek A, Litinsky I, et al
   Anti-inflammatory effects of infliximab and methotrexate on peripheral blood and synovial fluid mononuclear cells: ex vivo study.
   Scand J Rheumatol. 2024;53:188-198.
   PubMed     Abstract available
   
   
   March 2024
3. AHAMMAR S, Martinsson K, Ziegelasch M, Kastbom A, et al
   Prognostic value of serum protein electrophoresis constituents for arthritis development in anti-citrullinated protein antibody-positive patients with musculoskeletal pain.
   Scand J Rheumatol. 2024;53:118-122.
   PubMed     Abstract available
   
   
   February 2024
4. WANG J, Vordenbaumen S, Schneider M, Brinks R, et al
   Population-based epidemiological projections of rheumatoid arthritis in Germany until 2040.
   Scand J Rheumatol. 2024 Feb 15:1-12. doi: 10.1080/03009742.2024.2312693.
   PubMed     Abstract available
   
   
   January 2024
5. HOUGE IS, Hoff M, Videm V
   Self-determined motivation and physical activity in patients with rheumatoid arthritis: a cross-sectional study.
   Scand J Rheumatol. 2024 Jan 26:1-9. doi: 10.1080/03009742.2023.2300576.
   PubMed     Abstract available
   
   
   
6. YOO WH, Ha GW, Kim KM, Choi Y, et al
   When treatment takes a turn: tocilizumab-induced bowel perforation in a patient with COVID-19-afflicted rheumatoid arthritis.
   Scand J Rheumatol. 2024 Jan 10:1-3. doi: 10.1080/03009742.2023.2294580.
   PubMed    
   
   
   
7. ROGIND SS, Hetland ML
   Delayed identification of disseminated infection in a patient with rheumatoid arthritis and septic arthritis: a case report.
   Scand J Rheumatol. 2024;53:72-73.
   PubMed    
   
   
   December 2023
8. MICHITSUJI T, Fukui S, Morimoto S, Endo Y, et al
   Clinical and ultrasound features of difficult-to-treat rheumatoid arthritis: A multicenter RA ultrasound cohort study.
   Scand J Rheumatol. 2023 Dec 12:1-7. doi: 10.1080/03009742.2023.2277542.
   PubMed     Abstract available
   
   
   November 2023
9. KOMAI T, Sawada T, Tsuchiya H, Harada H, et al
   Resolution of exacerbated rheumatoid arthritis-associated interstitial lung disease under baricitinib treatment.
   Scand J Rheumatol. 2023 Nov 30:1-3. doi: 10.1080/03009742.2023.2274707.
   PubMed    
   
   
   
10. VAN WISSEN M, Straathof B, Vliet Vlieland T, van den Ende C, et al
    Construct validity of the PROMIS PF-10 in patients with inflammatory rheumatic diseases and severe limitations in physical functioning.
    Scand J Rheumatol. 2023;52:645-653.
    PubMed     Abstract available
    
    
    
11. ZENG M, Issotina Zibrila A, Li X, Liu X, et al
    Pyridostigmine ameliorates pristane-induced arthritis symptoms in Dark Agouti rats.
    Scand J Rheumatol. 2023;52:627-636.
    PubMed     Abstract available
    
    
    October 2023
12. BELAU MH, Flasskamp F, Becher H, Hajek A, et al
    Physical activity in adults with and without rheumatoid arthritis: cross-sectional results from the Survey of Health, Ageing and Retirement in Europe (SHARE).
    Scand J Rheumatol. 2023 Oct 31:1-6. doi: 10.1080/03009742.2023.2269672.
    PubMed     Abstract available
    
    
    September 2023
13. ZHANG Y, Zhu F, Liu C, Wang M, et al
    A case report of Sjogren's syndrome complicated with immune-mediated necrotizing myopathy.
    Scand J Rheumatol. 2023;52:580-583.
    PubMed    
    
    
    
14. UHRENHOLT L, Christensen R, Dreyer L, Hauge EM, et al
    Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trial.
    Scand J Rheumatol. 2023;52:481-492.
    PubMed     Abstract available
    
    
    
15. PFEIFFER-JENSEN M, Liao D, Tarp U, Deleuran B, et al
    Reduced prescription of TNF-inhibitors in chronic arthritis based on therapeutic drug monitoring: A randomized controlled trial.
    Scand J Rheumatol. 2023;52:468-480.
    PubMed     Abstract available
    
    
    July 2023
16. MCKEIGUE PM, Porter D, Hollick RJ, Ralston SH, et al
    Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland.
    Scand J Rheumatol. 2023;52:412-417.
    PubMed     Abstract available
    
    
    June 2023
17. SAHIN EROGLU D, Dalva K, Azap A, Kutlay NY, et al
    Two birds with one stone: a Bruton's tyrosine kinase inhibitor in a patient with rheumatoid arthritis and 17p + chronic lymphocytic leukaemia.
    Scand J Rheumatol. 2023 Jun 28:1-2. doi: 10.1080/03009742.2023.2218206.
    PubMed    
    
    
    May 2023
18. DE STEFANO L, Guerini M, Pelizza J, Ferracane G, et al
    A case of a rheumatoid nodule on the aortic valve in a patient with rheumatoid arthritis in sustained remission with anti-TNFalpha.
    Scand J Rheumatol. 2023 May 4:1-3. doi: 10.1080/03009742.2023.2201065.
    PubMed    
    
    
    
19. VAN WISSEN M, Gademan M, Vliet Vlieland T, Straathof B, et al
    Physical therapy in patients with rheumatoid arthritis and axial spondyloarthritis: the patients' perspective.
    Scand J Rheumatol. 2023 May 4:1-10. doi: 10.1080/03009742.2023.2195726.
    PubMed     Abstract available
    
    
    April 2023
20. FERREIRA MB, Kobayashi M, Costa RQ, Fonseca T, et al
    Unsupervised clustering to differentiate rheumatoid arthritis patients based on proteomic signatures.
    Scand J Rheumatol. 2023 Apr 21:1-8. doi: 10.1080/03009742.2023.2196781.
    PubMed     Abstract available
    
    
    
21. HYLDGAARD C, Harders S, Blegvad J, Herly M, et al
    Clinical and preclinical pulmonary disease in newly diagnosed rheumatoid arthritis: a two-year follow-up study.
    Scand J Rheumatol. 2023 Apr 17:1-8. doi: 10.1080/03009742.2023.2194105.
    PubMed     Abstract available
    
    
    March 2023
22. BLANKEN AB, Korteweg M, van Boheemen L, van Vollenhoven RF, et al
    Clinical evaluation of optical spectral transmission imaging for detection of disease activity in rheumatoid arthritis.
    Scand J Rheumatol. 2023 Mar 28:1-9. doi: 10.1080/03009742.2023.2177382.
    PubMed     Abstract available
    
    
    
23. RASMUSSEN SL, Strandbygaard LL, Fuursted K, Kragholm KH, et al
    Antibody response in patients with autoimmune inflammatory rheumatic disease after pneumococcal polysaccharide prime vaccination or revaccination.
    Scand J Rheumatol. 2023;52:174-180.
    PubMed     Abstract available
    
    
    
24. OLSSON P, Ekblad F, Hassler A, Bengtsson M, et al
    Complications after minor salivary gland biopsy: a retrospective study of 630 patients from two Swedish centres.
    Scand J Rheumatol. 2023;52:208-216.
    PubMed     Abstract available
    
    
    
25. YU X, Zhu F, Yu X, Wang J, et al
    Serum CCL28 as a biomarker for diagnosis and evaluation of Sjogren's syndrome.
    Scand J Rheumatol. 2023;52:200-207.
    PubMed     Abstract available
    
    
    February 2023
26. KARLSSON ML, Hertzberg-Nyquist K, Saevarsdottir S, Lundberg IE, et al
    Evaluation of an individually tailored smoking-cessation intervention for patients with rheumatoid arthritis in an outpatient clinic.
    Scand J Rheumatol. 2023 Feb 23:1-11. doi: 10.1080/03009742.2023.2172903.
    PubMed     Abstract available
    
    
    
27. LANDGREN AJ, Klingberg E, Jacobsson L, Bergsten U, et al
    Health-related quality of life in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis, results from a cross-sectional survey in Western Sweden.
    Scand J Rheumatol. 2023 Feb 6:1-13. doi: 10.1080/03009742.2022.2157962.
    PubMed     Abstract available
    
    
    January 2023
28. KOERS J, Derksen N, Falkenburg W, Ooijevaar-de Heer P, et al
    Elevated Fab glycosylation of anti-hinge antibodies.
    Scand J Rheumatol. 2023;52:25-32.
    PubMed     Abstract available
    
    
    November 2022
29. LIAO HT, Tung HY, Chou CT, Tsai HC, et al
    Immunogenicity of the mRNA-1273 and ChAdOx1 nCoV-19 vaccines in Asian patients with autoimmune rheumatic diseases under biologic and/or conventional immunosuppressant treatments.
    Scand J Rheumatol. 2022;51:500-505.
    PubMed     Abstract available
    
    
    October 2022
30. RASMUSSEN EB, Thiele LS, Stengaard-Pedersen K, Hetland ML, et al
    Baseline serum levels of IgA anti-cyclic citrullinated protein antibodies in early rheumatoid arthritis predict radiographic progression after 11 years of treatment: a secondary analysis of the CIMESTRA study.
    Scand J Rheumatol. 2022 Oct 18:1-5. doi: 10.1080/03009742.2022.2127245.
    PubMed     Abstract available
    
    
    September 2022
31. SIMONS G, Scholin Bywall K, Englbrecht M, Johansson EC, et al
    Exploring preferences of at-risk individuals for preventive treatments for rheumatoid arthritis.
    Scand J Rheumatol. 2022 Sep 30:1-11. doi: 10.1080/03009742.2022.2116805.
    PubMed     Abstract available
    
    
    
32. VAN BOHEEMEN L, Ter Wee MM, Falahee M, Filer A, et al
    The Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: predicting clinical arthritis development.
    Scand J Rheumatol. 2022 Sep 29:1-8. doi: 10.1080/03009742.2022.2116806.
    PubMed     Abstract available
    
    
    July 2022
33. HU H, Wang S
    Rheumatoid arthritis with coral reef aorta: a case report.
    Scand J Rheumatol. 2022 Jul 14:1-2. doi: 10.1080/03009742.2022.2082150.
    PubMed    
    
    
    
34. RAFT MB, Hetland ML, Brahe CH, Horslev-Petersen K, et al
    Serum 14-3-3eta as predictor of clinical remission and progression of structural damage in early rheumatoid arthritis following a treat-to-target strategy in a randomized controlled trial.
    Scand J Rheumatol. 2022 Jul 14:1-11. doi: 10.1080/03009742.2022.2087900.
    PubMed     Abstract available
    
    
    
35. CHEN D, Yin H, Tang G, Lu L, et al
    Efficacy of low-dose of baricitinib in the treatment of patchy alopecia and sicca syndrome in an SLE patient.
    Scand J Rheumatol. 2022 Jul 14:1-3. doi: 10.1080/03009742.2022.2087901.
    PubMed    
    
    
    
36. KRIJBOLDER DI, Verstappen M, Wouters F, Lard LR, et al
    Comparison between 1.5T and 3.0T MRI: both field strengths sensitively detect subclinical inflammation of hand and forefoot in patients with arthralgia.
    Scand J Rheumatol. 2022;51:284-290.
    PubMed     Abstract available
    
    
    June 2022
37. ZHANG K, Jia Y, Wang R, Guo D, et al
    Rheumatoid arthritis and the risk of major cardiometabolic diseases: a Mendelian randomization study.
    Scand J Rheumatol. 2022 Jun 6:1-7. doi: 10.1080/03009742.2022.2070988.
    PubMed     Abstract available
    
    
    May 2022
38. VENETSANOPOULOU AI, Alamanos Y, Skalkou A, Voulgari PV, et al
    The changing incidence of rheumatoid arthritis over time in north-west Greece: data from a referral centre.
    Scand J Rheumatol. 2022 May 12:1-8. doi: 10.1080/03009742.2022.2058178.
    PubMed     Abstract available
    
    
    
39. LEE NY, Kim NR, Kang JW, Kim G, et al
    Increased salivary syndecan-1 level is associated with salivary gland function and inflammation in patients with Sjogren's syndrome.
    Scand J Rheumatol. 2022;51:220-229.
    PubMed     Abstract available
    
    
    
40. FOHSE FK, Rollefstad S, Ikdahl E, Wibetoe G, et al
    Degree of arterial stiffness is comparable across inflammatory joint disease entities.
    Scand J Rheumatol. 2022;51:186-195.
    PubMed     Abstract available
    
    
    April 2022
41. DIEPERINK SS, Glintborg B, Oestergaard LB, Norgaard M, et al
    Risk of Staphylococcus aureus bacteraemia in patients with rheumatoid arthritis and the effect of orthopaedic implants on the risk: a nationwide observational cohort study.
    Scand J Rheumatol. 2022 Apr 20:1-9. doi: 10.1080/03009742.2022.2049057.
    PubMed     Abstract available
    
    
    March 2022
42. HESLINGA M, Teunissen C, Agca R, van der Woude D, et al
    NT-proBNP and sRAGE levels in early rheumatoid arthritis.
    Scand J Rheumatol. 2022 Mar 11:1-7. doi: 10.1080/03009742.2022.2042975.
    PubMed     Abstract available
    
    
    
43. ALSING CL, Nystad TW, Igland J, Gjesdal CG, et al
    Trends in the occurrence of ischaemic heart disease over time in rheumatoid arthritis: 1821 patients from 1972 to 2017.
    Scand J Rheumatol. 2022 Mar 11:1-10. doi: 10.1080/03009742.2022.2040116.
    PubMed     Abstract available
    
    
    
44. RUWAARD J, L' Ami MJ, Kneepkens EL, Krieckaert C, et al
    Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial.
    Scand J Rheumatol. 2022 Mar 2:1-8. doi: 10.1080/03009742.2022.2028364.
    PubMed     Abstract available
    
    
    
45. LIU Y, Wang Z, Ren L, Zeng Q, et al
    Sonographic findings of immunoglobulin G4-related sialadenitis and differences from Sjogren's syndrome.
    Scand J Rheumatol. 2022;51:128-134.
    PubMed     Abstract available
    
    
    January 2022
46. SKOVSGAARD CV, Kruse M, Hjollund N, Maribo T, et al
    Cost-effectiveness of a telehealth intervention in rheumatoid arthritis: economic evaluation of the Telehealth in RA (TeRA) randomized controlled trial.
    Scand J Rheumatol. 2022 Jan 20:1-11. doi: 10.1080/03009742.2021.2008604.
    PubMed     Abstract available
    
    
    
47. NIELSEN MA, Koster D, Greisen S, Troldborg A, et al
    Increased synovial galectin-3 induce inflammatory fibroblast activation and osteoclastogenesis in patients with rheumatoid arthritis.
    Scand J Rheumatol. 2022 Jan 13:1-9. doi: 10.1080/03009742.2021.1992860.
    PubMed     Abstract available
    
    
    
48. MOLANDER V, Bower H, Askling J
    Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis.
    Scand J Rheumatol. 2022 Jan 13:1-7. doi: 10.1080/03009742.2021.2001907.
    PubMed     Abstract available
    
    
    
49. GLOYER L, Golumba-Nagy V, Meyer A, Yan S, et al
    Adenosine receptor A2a blockade by caffeine increases IFN-gamma production in Th1 cells from patients with rheumatoid arthritis.
    Scand J Rheumatol. 2022 Jan 13:1-5. doi: 10.1080/03009742.2021.1995956.
    PubMed     Abstract available
    
    
    
50. CARRARA G, Argnani L, Zanetti A, Zabotti A, et al
    Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology.
    Scand J Rheumatol. 2022 Jan 13:1-5. doi: 10.1080/03009742.2021.2003033.
    PubMed     Abstract available
    
    
    
51. KEROLA AM, Rollefstad S, Kazemi A, Wibetoe G, et al
    Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents.
    Scand J Rheumatol. 2022 Jan 11:1-9. doi: 10.1080/03009742.2021.1997436.
    PubMed     Abstract available
    
    
    
52. UHRENHOLT L, Christensen R, Dreyer L, Schlemmer A, et al
    Using a novel smartphone application for capturing of patient-reported outcome measures among patients with inflammatory arthritis:A randomized, crossover, agreement study.
    Scand J Rheumatol. 2022;51:25-33.
    PubMed     Abstract available
    
    
    
53. OTTAVIANI S, Khaleche S, Borie R, Debray MP, et al
    Rheumatological evaluation of patients with interstitial lung disease.
    Scand J Rheumatol. 2022;51:34-41.
    PubMed     Abstract available
    
    
    
54. KITADA T, Kadoba K, Watanabe R, Koyama T, et al
    Listeriosis presenting with fever, arthralgia, elevated liver enzymes, and hyperferritinaemia in pregnancy: a critical mimicker of adult-onset Still's disease.
    Scand J Rheumatol. 2022;51:78-80.
    PubMed    
    
    
    December 2021
55. SOUSSI BG, Cordtz RL, Kristensen S, Bork CS, et al
    Incidence and prevalence of rheumatoid arthritis in Denmark from 1998 to 2018: a nationwide register-based study.
    Scand J Rheumatol. 2021 Dec 16:1-9. doi: 10.1080/03009742.2021.1957557.
    PubMed     Abstract available
    
    
    November 2021
56. THOMSEN T, Esbensen BA, Hetland ML, Aadahl M, et al
    Characteristics of participants and decliners from a randomized controlled trial on physical activity in patients with rheumatoid arthritis: a retrospective register-based cross-sectional study.
    Scand J Rheumatol. 2021 Nov 2:1-8. doi: 10.1080/03009742.2021.1975394.
    PubMed     Abstract available
    
    
    
57. GEHIN JE, Warren DJ, Syversen SW, Lie E, et al
    Serum golimumab concentration and anti-drug antibodies are associated with treatment response and drug survival in patients with inflammatory joint diseases: data from the NOR-DMARD study.
    Scand J Rheumatol. 2021;50:445-454.
    PubMed     Abstract available
    
    
    October 2021
58. PALTTA J, Heikkila HK, Pirila L, Eklund KK, et al
    The validity of rheumatoid arthritis diagnoses in Finnish biobanks.
    Scand J Rheumatol. 2021 Oct 13:1-9. doi: 10.1080/03009742.2021.1967047.
    PubMed     Abstract available
    
    
    
59. ANGSTROM L, Hornberg K, Sundstrom B, Sodergren A, et al
    Rheumatoid cachexia in early rheumatoid arthritis: prevalence and associated variables.
    Scand J Rheumatol. 2021 Oct 13:1-7. doi: 10.1080/03009742.2021.1973678.
    PubMed     Abstract available
    
    
    
60. AMRIS K, Bandak E, Kristensen LE, Waehrens EE, et al
    Agreement between self-reported and observed functioning in patients with rheumatoid arthritis, osteoarthritis, and fibromyalgia, and the influence of pain and fatigue: a cross-sectional study.
    Scand J Rheumatol. 2021 Oct 1:1-9. doi: 10.1080/03009742.2021.1952755.
    PubMed     Abstract available
    
    
    September 2021
61. JENSEN R, Christensen AF, Hartlev LB, Thomsen JS, et al
    Calcified cartilage differs in patients with end-stage primary osteoarthritis and secondary osteoarthritis due to rheumatoid arthritis of the hip joint.
    Scand J Rheumatol. 2021 Sep 13:1-11. doi: 10.1080/03009742.2021.1952754.
    PubMed     Abstract available
    
    
    
62. THOMAS PE, Aarestrup J, Jacobsen S, Jensen BW, et al
    Birthweight, body size, and growth during childhood and risks of rheumatoid arthritis: a large Danish cohort study.
    Scand J Rheumatol. 2021 Sep 13:1-9. doi: 10.1080/03009742.2021.1954772.
    PubMed     Abstract available
    
    
    
63. BERTRAND D, Stouten V, De Cock D, Pazmino S, et al
    Tapering of Etanercept is feasible in patients with Rheumatoid Arthritis in sustained remission: a pragmatic randomized controlled trial.
    Scand J Rheumatol. 2021 Sep 13:1-11. doi: 10.1080/03009742.2021.1955467.
    PubMed     Abstract available
    
    
    
64. MARS N, Kerola AM, Kauppi MJ, Pirinen M, et al
    Cluster analysis identifies unmet healthcare needs among patients with rheumatoid arthritis.
    Scand J Rheumatol. 2021 Sep 13:1-8. doi: 10.1080/03009742.2021.1944306.
    PubMed     Abstract available
    
    
    
65. NAKAYAMA Y, Hashimoto M, Watanabe R, Murakami K, et al
    Favorable clinical response and drug retention of anti-IL-6 receptor inhibitor in rheumatoid arthritis with high CRP levels: the ANSWER cohort study.
    Scand J Rheumatol. 2021 Sep 13:1-10. doi: 10.1080/03009742.2021.1947005.
    PubMed     Abstract available
    
    
    
66. MOLLER-BISGAARD S, Horslev-Petersen K, Ejbjerg B, Hetland ML, et al
    Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial.
    Scand J Rheumatol. 2021 Sep 2:1-11. doi: 10.1080/03009742.2021.1935312.
    PubMed     Abstract available
    
    
    
67. ENDO Y, Kawashiri SY, Nishino A, Michitsuji T, et al
    Ultrasound efficacy of targeted-synthetic disease-modifying anti-rheumatic drug treatment in rheumatoid arthritis: a multicenter prospective cohort study in Japan.
    Scand J Rheumatol. 2021 Sep 2:1-9. doi: 10.1080/03009742.2021.1927389.
    PubMed     Abstract available
    
    
    
68. ANDERSSON M, Svensson B, Bergman S
    Pain in rheumatoid arthritis: a seven-year follow-up study of pain distribution and factors associated with transition from and to chronic widespread pain.
    Scand J Rheumatol. 2021 Sep 1:1-10. doi: 10.1080/03009742.2021.1944304.
    PubMed     Abstract available
    
    
    
69. CIAFFI J, Giuggioli D, Spinella A, Meliconi R, et al
    Resilience of systemic sclerosis patients following the first COVID-19 wave in Italy.
    Scand J Rheumatol. 2021;50:411-412.
    PubMed    
    
    
    July 2021
70. VUOLTEENAHO K, Tuure L, Nieminen R, Laasonen L, et al
    Pretreatment resistin levels are associated with erosive disease in early rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs and infliximab.
    Scand J Rheumatol. 2021 Jul 15:1-6. doi: 10.1080/03009742.2021.1929456.
    PubMed     Abstract available
    
    
    
71. CAO C, Shao Q, Yang H
    Sjogren's syndrome concurrent with organizing pneumonia with secondary systemic capillary leak syndrome: a case report.
    Scand J Rheumatol. 2021;50:322-324.
    PubMed    
    
    
    June 2021
72. PEDERSEN JK, Andersen K, Svendsen AJ, Horslev-Petersen K, et al
    No difference in antidepressant prescription in rheumatoid arthritis and controls. Results from a population-based, matched inception cohort.
    Scand J Rheumatol. 2021 Jun 29:1-7. doi: 10.1080/03009742.2021.1923148.
    PubMed     Abstract available
    
    
    
73. MCCOY SS, Greenlee RT, VanWormer JJ, Schletzbaum M, et al
    Smoking associated with reduced odds of Sjogren's syndrome among rheumatoid arthritis patients.
    Scand J Rheumatol. 2021 Jun 25:1-5. doi: 10.1080/03009742.2021.1925584.
    PubMed     Abstract available
    
    
    
74. VERSTEEG GA, Steunebrink L, Vonkeman HE, Ten Klooster PM, et al
    Early radiological progression remains associated with long-term joint damage in real-world rheumatoid arthritis patients treated to the target of remission.
    Scand J Rheumatol. 2021 Jun 21:1-10. doi: 10.1080/03009742.2021.1917161.
    PubMed     Abstract available
    
    
    
75. TAN YK, Teo P, Saffari SE, Xin X, et al
    A musculoskeletal ultrasound program as an intervention to improve disease modifying anti-rheumatic drugs adherence in rheumatoid arthritis: a randomized controlled trial.
    Scand J Rheumatol. 2021 Jun 10:1-9. doi: 10.1080/03009742.2021.1901416.
    PubMed     Abstract available
    
    
    May 2021
76. SCHAFER C
    Early description of polyarthritis possibly representing rheumatoid arthritis given by a patient, as recorded in a textbook on gout from 1788.
    Scand J Rheumatol. 2021 May 5:1-2. doi: 10.1080/03009742.2021.1894824.
    PubMed    
    
    
    
77. ELOFF E, Martinsson K, Ziegelasch M, Cedergren J, et al
    Autoantibodies are major predictors of arthritis development in patients with anti-citrullinated protein antibodies and musculoskeletal pain.
    Scand J Rheumatol. 2021;50:189-197.
    PubMed     Abstract available
    
    
    April 2021
78. GAO J, Xin L, Guo Q, Xu K, et al
    Twenty-year changes in mortality rates and underlying causes of death in patients with rheumatoid arthritis-associated interstitial lung disease.
    Scand J Rheumatol. 2021 Apr 14:1-5. doi: 10.1080/03009742.2021.1882557.
    PubMed     Abstract available
    
    
    March 2021
79. SHAO Q, Wang S, Jiang H, Liu L, et al
    Efficacy and safety of iguratimod on patients with primary Sjogren's syndrome: a randomized, placebo-controlled clinical trial.
    Scand J Rheumatol. 2021;50:143-152.
    PubMed     Abstract available
    
    
    
80. KONONOFF A, Horkko S, Pussinen P, Kautiainen H, et al
    Antibodies to malondialdehyde-acetaldehyde modified low-density lipoprotein in patients with newly diagnosed inflammatory joint disease.
    Scand J Rheumatol. 2021;50:113-117.
    PubMed     Abstract available
    
    
    
81. LAVERE P, Sonkar J, Du X, Qian YW, et al
    Macrophage activation syndrome complicating adult onset Still's disease: a case report.
    Scand J Rheumatol. 2021;50:161-162.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.